The world’s leading provider of intellectual property support services (patent translations, international patent filing solutions and searches) and a leading provider of life sciences and commercial language services.
Trading Update For The Year To End September 2017 – The headline is “An outstanding year, strengthening our leading position in Life Sciences”. Revenues expected to be £163m vs £122m (33%+). Adjusted PBT is also expected to be ahead of market expectations. The group has benefitted from a weak GBP (80% of Revenues in EUR and USD). EUR hedge is in place for 2018.
On a PER of 27 I would still be tempted to wait and see the actuals here (Revenue in CC) and actual Profits. Perhaps I am just too cautious!